TY - JOUR
T1 - Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies
AU - Visioli, Alberto
AU - Giani, Fabrizio
AU - Trivieri, Nadia
AU - Pracella, Riccardo
AU - Miccinilli, Elide
AU - Cariglia, Maria Grazia
AU - Palumbo, Orazio
AU - Arleo, Andrea
AU - Dezi, Fabio
AU - Copetti, Massimiliano
AU - Cajola, Laura
AU - Restelli, Silvia
AU - Papa, Valerio
AU - Sciuto, Antonio
AU - Latiano, Tiziana Pia
AU - Carella, Massimo
AU - Amadori, Dino
AU - Gallerani, Giulia
AU - Ricci, Riccardo
AU - Alfieri, Sergio
AU - Pesole, Graziano
AU - Vescovi, Angelo L.
AU - Binda, Elena
N1 - Publisher Copyright:
© 2019
PY - 2019/6
Y1 - 2019/6
N2 - Background: Despite their lethality and ensuing clinical and therapeutic relevance, circulating tumor cells (CTCs) from colorectal carcinoma (CRC) remain elusive, poorly characterized biological entities. Methods and findings: We perfected a cell system of stable, primary lines from human CRC showing that they possess the full complement of ex- and in-vivo, in xenogeneic models, characteristics of CRC stem cells (CCSCs). Here we show how tumor-initiating, CCSCs cells can establish faithful orthotopic phenocopies of the original disease, which contain cells that spread into the circulatory system. While in the vascular bed, these cells retain stemness, thus qualifying as circulating CCSCs (cCCSCs). This is followed by the establishment of lesions in distant organs, which also contain resident metastatic CCSCs (mCCSCs). Interpretation: Our results support the concept that throughout all the stages of CRC, stemness is retained as a continuous property by some of their tumor cells. Importantly, we describe a useful standardized model that can enable isolation and stable perpetuation of human CRC's CCSCs, cCCSCs and mCCSCs, providing a useful platform for studies of CRC initiation and progression that is suitable for the discovery of reliable stage-specific biomarkers and the refinement of new patient-tailored therapies. Fund: This work was financially supported by grants from “Ministero della Salute Italiano”(GR-2011-02351534, RC1703IC36 and RC1803IC35) to Elena Binda and from “Associazione Italiana Cancro” (IG-14368) Angelo L. Vescovi. None of the above funders have any role in study design, data collection, data analysis, interpretation, writing the project.
AB - Background: Despite their lethality and ensuing clinical and therapeutic relevance, circulating tumor cells (CTCs) from colorectal carcinoma (CRC) remain elusive, poorly characterized biological entities. Methods and findings: We perfected a cell system of stable, primary lines from human CRC showing that they possess the full complement of ex- and in-vivo, in xenogeneic models, characteristics of CRC stem cells (CCSCs). Here we show how tumor-initiating, CCSCs cells can establish faithful orthotopic phenocopies of the original disease, which contain cells that spread into the circulatory system. While in the vascular bed, these cells retain stemness, thus qualifying as circulating CCSCs (cCCSCs). This is followed by the establishment of lesions in distant organs, which also contain resident metastatic CCSCs (mCCSCs). Interpretation: Our results support the concept that throughout all the stages of CRC, stemness is retained as a continuous property by some of their tumor cells. Importantly, we describe a useful standardized model that can enable isolation and stable perpetuation of human CRC's CCSCs, cCCSCs and mCCSCs, providing a useful platform for studies of CRC initiation and progression that is suitable for the discovery of reliable stage-specific biomarkers and the refinement of new patient-tailored therapies. Fund: This work was financially supported by grants from “Ministero della Salute Italiano”(GR-2011-02351534, RC1703IC36 and RC1803IC35) to Elena Binda and from “Associazione Italiana Cancro” (IG-14368) Angelo L. Vescovi. None of the above funders have any role in study design, data collection, data analysis, interpretation, writing the project.
KW - Anti-CRC SCs strategies
KW - CRC biology and biomarkers
KW - CRC circulating stem cells
KW - CRC metastatic stem cells
KW - CRC stem cells
KW - Human colorectal carcinoma (CRC)
KW - Stemness
UR - http://www.scopus.com/inward/record.url?scp=85065043673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065043673&partnerID=8YFLogxK
U2 - 10.1016/j.ebiom.2019.04.049
DO - 10.1016/j.ebiom.2019.04.049
M3 - Article
C2 - 31056474
AN - SCOPUS:85065043673
SN - 2352-3964
VL - 44
SP - 346
EP - 360
JO - EBioMedicine
JF - EBioMedicine
ER -